Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
比较纳武利尤单抗和瑞戈非尼作为索拉非尼治疗失败后肝细胞癌患者的二线系统治疗方案
期刊:Yonsei Medical Journal
影响因子:2.8
doi:10.3349/ymj.2023.0263
Lee, Hong Jun; Lee, Jae Seung; So, Hyesung; Yoon, Ja Kyung; Choi, Jin-Young; Lee, Hye Won; Kim, Beom Kyung; Kim, Seung Up; Park, Jun Yong; Ahn, Sang Hoon; Kim, Do Young